Skip to content

Evaluating Efficacy of traditional preparation containing Bunium persicum and Coriandrum sativum on clinical symptoms of patients with functional dyspepsia

Evaluating Efficacy of traditional preparation containing Bunium persicum and Coriandrum sativum on clinical symptoms of patients with functional dyspepsia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190304042911N1
Enrollment
45
Registered
2019-11-03
Start date
2019-04-06
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group: 250 mg cumin powder and 250 mg coriander seed, twice daily after meal, for 4 weeks. Intervention 2: Control group: Capsule containing 500 mg of starch powder, twice

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Ages 18-60 years Functional dyspepsia based on Rome 4 criteria and with a diagnosis of gastrointestinal specialty No exclusion criteria

Exclusion criteria

Exclusion criteria: Pregnant patients Lactation People with allergies to ginger, fennel, dill and other herbs similar Hemorrhagic diseases (due to the effect of cumin on slowing clot formation) History of gastrointestinal ulcer or reflux disease Irritable Bowel Syndrome History of surgery in the esophagus, stomach and intestines Any type of drug use, severe mental retardation Warning Signs (Weight Loss, Anemia, Stool Blood)

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: Baseline, after 4, and 8 weeks. Method of measurement: Nepean dyspepsia quality of life questionnaire.

Secondary

MeasureTime frame
Dyspepsia severity. Timepoint: Baseline, after 4, and 8 weeks. Method of measurement: Dyspepsia severity scale.;Dyspepsia frequency. Timepoint: Baseline, after 4, and 8 weeks. Method of measurement: Rome IV questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobeh Esfandiarpoor

Kerman University of Medical Sciences

m.esfandiarpoor.87@gmail.com+98 34 4230 6385

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026